StockUS listing USLIVNNASDAQHealthcareQuality Compounder

LivaNova PLC(LIVN) Stock Analysis | Healthcare

USD --+0.00%
Reward58Moderate
Risk41Moderate
75%Data
USD —+0.00 (+0.00%) Previous close · NASDAQ
Market cap 5.03Bn
Reward Ratingⓘ58 Moderate reward assessment · 75% data coverage
Top 50% of stocksView factors
Risk Ratingⓘ41 Moderate risk assessment
Risk factors availableUnlock details

Educational tool only – Scores are based on historical data and financial metrics for informational purposes. This is not financial advice or a recommendation to buy or sell any security. Always conduct your own research or consult a qualified financial adviser.

Educational tool only · More
Limited data coverage
We don't have enough public data on LIVN to score it reliably yet — Reward, Risk, Forecasts and Dividends tabs aren't available for this stock. The price chart and basic profile are still shown.
OTC / ADR stock — scores and fundamentals use data tagged in USD by our provider. The issuer may report in a different home currency (e.g. JPY), so treat figures as directional rather than precise.
Not available yet for this stock
The overview tab requires data we don't have for this stock yet. The price chart is the most reliable view we have — try the Chart tab.
Earnings Ex-dividend

Market Performance

Stock returned +10.0% over the past year, broadly in line with market conditions.

What is LivaNova PLC?

LivaNova PLC, a medical technology company, designs, develops, manufactures, markets, and sells products, therapies, and services.

AI Brief Pro

The brief on LivaNova PLC

The story behind the price, the case for and against, and what could go wrong. Open a part to read it.

What is LivaNova PLC?

LivaNova PLC, a medical technology company, designs, develops, manufactures, markets, and sells products, therapies, and services. The company operates in two segments, Cardiopulmonary and Neuromodulation. The company is listed on the NASDAQ in USA, operating in the Healthcare sector, with a market capitalisation of 5.03B, and a P/E ratio of 26.2x.

Financial Highlights

Investment Breakdown

Growth
Moderate growth momentum — positive trajectory without breakout acceleration.
Profitability
Adequate profitability with some margin variability in recent periods.
Risk
Risk profile appears balanced versus broad market conditions.
Valuation
Valuation appears fair relative to current fundamentals.

OpenBook Logo Analysis

Reward: Moderate (58)

Similar stocks to compare

A short list of Medical Devices names that are close enough in size to make side-by-side comparison useful.

Company Information
SectorHealthcare
IndustryMedical Devices
P/E Ratio26.1662
Beta0.921
Insider Activity
12M windowQuiet
Fewer than three real open-market insider trades in the last 12 months. Mechanical activity (option exercises, RSU vests) is excluded from the signal.